Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

Is AstraZeneca plc Still A Buy After The 2013 FTSE Bull Run?

| Roland Head

AstraZeneca plc (LON:AZN) has kept pace with the FTSE this year, but remains an appealing recovery story.

Read more »

Investing Articles

3 FTSE Shares Hitting New Highs: Drax Group Plc, Smith & Nephew plc and AstraZeneca plc

| Alan Oscroft

Drax Group Plc (LON: DRX), Smith & Nephew plc (LON: SN) and AstraZeneca plc (LON: AZN) are soaring.

Read more »

Investing Articles

AstraZeneca plc Could Help You Retire Early

| Peter Stephens

Retirement may not be so long away for shareholders in AstraZeneca plc (LON: AZN). Here’s why...

Read more »

Investing Articles

Can AstraZeneca plc’s Share Price Return To 3,625p?

| Rupert Hargreaves

Will AstraZeneca plc (LON: AZN) be able to return to its previous highs?

Read more »

Investing Articles

The Warren Buffett Bear Case For AstraZeneca plc

| G A Chester

A Buffett fan considers the investment case for AstraZeneca plc (LON:AZN).

Read more »

Investing Articles

AstraZeneca plc Could Be Worth 3915p

| Peter Stephens

Shareholders in AstraZeneca plc (LON: AZN) could enjoy gains of 18.5% plus a generous dividend. Here’s why…

Read more »

Investing Articles

Why AstraZeneca plc Will Be One Of 2013’s Winners

| Alan Oscroft

It's a close run for AstraZeneca plc (LON: AZN) as we approach the end of the year.

Read more »

Investing Articles

A SWOT Analysis Of AstraZeneca Plc And GlaxoSmithKline plc

| David O'Hara

What are the key factors affecting the investment proposition at pharmaceutical giants GlaxoSmithKline plc (LON:GSK) and AstraZeneca plc (LON:AZN)?

Read more »

Investing Articles

Angels vs Devils: Should You Invest In AstraZeneca plc?

| Royston Wild

Royston Wild considers the pros and cons of investing in AstraZeneca plc (LON: AZN).

Read more »

Investing Articles

This Model Suggests AstraZeneca plc Could Deliver A 6.3% Annual Return

| Roland Head

Roland Head explains why AstraZeneca plc (LON:AZN) could deliver a 6.3% annual return over the next few years.

Read more »

Company Comment

AstraZeneca Plc’s Turnaround Story Hasn’t Started Yet

| Keith Speights

The turnaround story at AstraZeneca plc (LON:AZN) may require a good deal more time to even begin...

Read more »

Investing Videos

Is AstraZeneca Plc A Good Way To Play Emerging Markets?

| Owain Bennallack

VIDEO: One Fool weighs up the emerging-market potential of AstraZeneca plc (LON:AZN).

Read more »